1. |
Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy, 2007, 62(2):102-112.
|
2. |
Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2009. Available at: http://ginasthma.org.
|
3. |
Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol, 2004, 113(1):59-65.
|
4. |
Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnair to measure asthma control. Eur Respir J, 1999, 14(4):902-907.
|
5. |
Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA)2015.Available at: http://ginasthma.org.
|
6. |
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案). 中华结核和呼吸杂志, 2008, 31(3): 177-185.
|
7. |
Wang G, Zhou T, Wang L, et al. Relationship between current psychological symptoms and future risk of asthma outcomes: a 12-month prospective cohort study. J Asthma, 2011, 48(10): 1041-1050.
|
8. |
Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol, 2003, 112(2): 252-262.
|
9. |
Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol, 1992, 45(5): 461-472.
|
10. |
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005, 26(5):948-968.
|
11. |
郑劲平, 主编. 肺功能学: 基础与临床. 广州: 广东科技出版社, 2007, 8.
|
12. |
郑洁, 张欣, 郑静, 等. 肥胖与支气管哮喘控制水平及气道炎症表型的关系. 中国呼吸与危重监护杂志, 2015, 14(6):578-584.
|
13. |
Wang G, Baines KJ, Fu JJ, et al. Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. Eur Respir J, 2016, 47(4):1121-1133.
|
14. |
Simpson JL, Phipps S, Baines KJ, et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J, 2014, 43(4):1067-1076.
|
15. |
Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration, 2010, 79(2):147-151.
|
16. |
Meng XL, Rosenthal R, Rubin DB. Comparing correlated correlation coefficients. Psychol Bull, 1992, 111(1):172-175.
|
17. |
吕媛, 易银沙. 关联相关系数的比较. 实用预防医学, 2001, 8(2): 157-158.
|
18. |
Bailey WC, Higgins DM, Richards BM, et al. Asthma severity: a factor analytic investigation. Am J Med, 1992, 93(3): 263-269.
|
19. |
Rosi E, Ronchi MC, Grazzini M, et al. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol, 1999, 103(2 Pt 1): 232-237.
|
20. |
Kerstjens HA, Brand PL, de Jong PM, et al. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. Thorax, 1994, 49(11):1109-1115.
|
21. |
Jenkins CR, Thien FC, Wheatley JR, et al. Traditional and patient-centred outcomes with three classes of asthma medication. Eur Respir J, 2005, 26(1): 36-44.
|
22. |
Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J, 2015, 46(3): 579-582.
|
23. |
Li HL, He XL, Liang BM, et al. Anxiety but not depression symptoms are associated with greater perceived dyspnea in asthma during bronchoconstriction. Allergy Asthma Proc, 2015, 36(6):447-457.
|
24. |
Osborne ML, Pedula KL, O’Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest, 2007, 132(4): 1151-1161.
|
25. |
Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest, 2004, 126(6):1875-1882.
|
26. |
Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol, 2001, 107(1):61-67.
|
27. |
Melter EO, Busse WW, Wenzel SE, et al. Use of the Asthma Control Questionaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol, 2011, 127(1):167-172.
|
28. |
McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol, 2006, 118(6):1226-1233.
|
29. |
Schatz M, Zeiger RS, Yang SJ, et al. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest, 2012, 141(1):66-72.
|
30. |
Wei HH, Zhou T, Wang L, et al. Current asthma control predicts future risk of asthma exacerbation: a 12-month prospective cohort study. Chin Med J, 2012, 125(17):2986-2993.
|
31. |
Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy, 2012, 42(5):747-759.
|
32. |
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy, 2008, 63 Suppl 86:8-160.
|
33. |
Wechsler ME, Kelley JM, Boyd IO, et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med, 2011, 365(2): 119-126.
|
34. |
Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA, 2001, 285(20):2583-2593.
|
35. |
Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol, 2010; 125(3): 600-608.
|
36. |
Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicenter, double-blind, placebo-controlled trial. Lancet, 2012, 380(9842): 651-659.
|
37. |
Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med, 2008, 178(3): 218-224.
|
38. |
Volbeda F, Broekema M, Lodewijk ME, et al. Clinical control of asthma associates with measures of airway inflammation. Thorax, 2013, 68(1):19-24.
|